Trisomy 12 compromises the mesendodermal differentiation propensity of human pluripotent stem cells

Kana Yanagihara,Yohei Hayashi,Yujung Liu,Tomoko Yamaguchi,Yasuko Hemmi,Minako Kokunugi,Kozue Uchio Yamada,Ken Fukumoto,Mika Suga,Satoshi Terada,Hiroki Nikawa,Kenji Kawabata,Miho Furue
DOI: https://doi.org/10.1007/s11626-023-00824-9
2024-01-03
In Vitro Cellular & Developmental Biology - Animal
Abstract:Trisomy 12 is one of the most frequent chromosomal abnormalities in cultured human pluripotent stem cells (hPSCs). Although potential oncogenic properties and augmented cell cycle caused by trisomy 12 have been reported, the consequences of trisomy 12 in terms of cell differentiation, which is the basis for regenerative medicine, drug development, and developmental biology studies, have not yet been investigated. Here, we report that trisomy 12 compromises the mesendodermal differentiation of hPSCs. We identified sublines of hPSCs carrying trisomy 12 after their prolonged culture. Transcriptome analysis revealed that these hPSC sublines carried abnormal gene expression patterns in specific signaling pathways in addition to cancer-related cell cycle pathways. These hPSC sublines showed a lower propensity for mesendodermal differentiation in embryoid bodies cultured in a serum-free medium. BMP4-induced exit from the self-renewal state was impaired in the trisomy 12 hPSC sublines, with less upregulation of key transcription factor gene expression. As a consequence, the differentiation efficiency of hematopoietic and hepatic lineages was also impaired in the trisomy 12 hPSC sublines. We reveal that trisomy 12 disrupts the genome-wide expression patterns that are required for proper mesendodermal differentiation.
cell biology,developmental biology
What problem does this paper attempt to address?